244 related articles for article (PubMed ID: 15159277)
1. Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury.
Proctor LM; Arumugam TV; Shiels I; Reid RC; Fairlie DP; Taylor SM
Br J Pharmacol; 2004 Jun; 142(4):756-64. PubMed ID: 15159277
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine.
Arumugam TV; Shiels IA; Woodruff TM; Reid RC; Fairlie DP; Taylor SM
J Surg Res; 2002 Apr; 103(2):260-7. PubMed ID: 11922743
[TBL] [Abstract][Full Text] [Related]
3. Complement inhibitors selectively attenuate injury following administration of cobra venom factor to rats.
Proctor LM; Strachan AJ; Woodruff TM; Mahadevan IB; Williams HM; Shiels IA; Taylor SM
Int Immunopharmacol; 2006 Aug; 6(8):1224-32. PubMed ID: 16782534
[TBL] [Abstract][Full Text] [Related]
4. Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhage.
Garrett MC; Otten ML; Starke RM; Komotar RJ; Magotti P; Lambris JD; Rynkowski MA; Connolly ES
Brain Res; 2009 Nov; 1298():171-7. PubMed ID: 19410563
[TBL] [Abstract][Full Text] [Related]
5. C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent.
Ducruet AF; Hassid BG; Mack WJ; Sosunov SA; Otten ML; Fusco DJ; Hickman ZL; Kim GH; Komotar RJ; Mocco J; Connolly ES
J Cereb Blood Flow Metab; 2008 May; 28(5):1048-58. PubMed ID: 18197178
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats.
Arumugam TV; Woodruff TM; Stocks SZ; Proctor LM; Pollitt S; Shiels IA; Reid RC; Fairlie DP; Taylor SM
J Hepatol; 2004 Jun; 40(6):934-41. PubMed ID: 15158333
[TBL] [Abstract][Full Text] [Related]
7. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
[TBL] [Abstract][Full Text] [Related]
8. A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats.
Arumugam TV; Shiels IA; Strachan AJ; Abbenante G; Fairlie DP; Taylor SM
Kidney Int; 2003 Jan; 63(1):134-42. PubMed ID: 12472776
[TBL] [Abstract][Full Text] [Related]
9. Complement factors C3a and C5a have distinct hemodynamic effects in the rat.
Proctor LM; Moore TA; Monk PN; Sanderson SD; Taylor SM; Woodruff TM
Int Immunopharmacol; 2009 Jun; 9(6):800-6. PubMed ID: 19285573
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist.
Strachan AJ; Shiels IA; Reid RC; Fairlie DP; Taylor SM
Br J Pharmacol; 2001 Dec; 134(8):1778-86. PubMed ID: 11739255
[TBL] [Abstract][Full Text] [Related]
11. Effects of peripherally and centrally applied ghrelin in the pathogenesis of ischemia-reperfusion induced injury of the small intestine.
Pawlik MW; Obuchowicz R; Biernat J; Szczepanski W; Pajdo R; Kwiecień S; Brzozowski T; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2011 Aug; 62(4):429-39. PubMed ID: 22100844
[TBL] [Abstract][Full Text] [Related]
12. [The effect of C3a, C5a and their receptor antagonists on the expression of beta-catenin in renal tubular cells].
Liu F; Gou R; Huang J; Fu P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):74-7. PubMed ID: 21355306
[TBL] [Abstract][Full Text] [Related]
13. Role of the complement components C5 and C3a in a mouse model of myocardial ischemia and reperfusion injury.
Busche MN; Stahl GL
Ger Med Sci; 2010 Sep; 8():. PubMed ID: 20930931
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of complement activation products c3a and c5a on cardiovascular function in hypertensive pregnant rats.
Lillegard KE; Loeks-Johnson AC; Opacich JW; Peterson JM; Bauer AJ; Elmquist BJ; Regal RR; Gilbert JS; Regal JF
J Pharmacol Exp Ther; 2014 Nov; 351(2):344-51. PubMed ID: 25150279
[TBL] [Abstract][Full Text] [Related]
15. Complement activation sustains neuroinflammation and deteriorates adult neurogenesis and spatial memory impairment in rat hippocampus following sleep deprivation.
Wadhwa M; Prabhakar A; Anand JP; Ray K; Prasad D; Kumar B; Panjwani U
Brain Behav Immun; 2019 Nov; 82():129-144. PubMed ID: 31408672
[TBL] [Abstract][Full Text] [Related]
16. Effects of a new C5a receptor antagonist on C5a- and endotoxin-induced neutropenia in the rat.
Short A; Wong AK; Finch AM; Haaima G; Shiels IA; Fairlie DP; Taylor SM
Br J Pharmacol; 1999 Feb; 126(3):551-4. PubMed ID: 10188960
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibitor lactacystin ablates liver injury induced by intestinal ischaemia-reperfusion.
Yao JH; Li YH; Wang ZZ; Zhang XS; Wang YZ; Yuan JC; Zhou Q; Liu KX; Tian XF
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1102-8. PubMed ID: 17880361
[TBL] [Abstract][Full Text] [Related]
18. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models.
Ames RS; Lee D; Foley JJ; Jurewicz AJ; Tornetta MA; Bautsch W; Settmacher B; Klos A; Erhard KF; Cousins RD; Sulpizio AC; Hieble JP; McCafferty G; Ward KW; Adams JL; Bondinell WE; Underwood DC; Osborn RR; Badger AM; Sarau HM
J Immunol; 2001 May; 166(10):6341-8. PubMed ID: 11342658
[TBL] [Abstract][Full Text] [Related]
19. Synthetic small-molecule complement inhibitors.
Holland MC; Morikis D; Lambris JD
Curr Opin Investig Drugs; 2004 Nov; 5(11):1164-73. PubMed ID: 15573867
[TBL] [Abstract][Full Text] [Related]
20. Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis.
Bao L; Osawe I; Haas M; Quigg RJ
J Immunol; 2005 Aug; 175(3):1947-55. PubMed ID: 16034139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
